0001140361-23-057390.txt : 20231212
0001140361-23-057390.hdr.sgml : 20231212
20231212205109
ACCESSION NUMBER: 0001140361-23-057390
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231207
FILED AS OF DATE: 20231212
DATE AS OF CHANGE: 20231212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Woods Keith
CENTRAL INDEX KEY: 0001996804
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36829
FILM NUMBER: 231482792
MAIL ADDRESS:
STREET 1: C/O X4 PHARMACEUTICALS INC.
STREET 2: 61 NORTH BEACON STREET 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ROCKET PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001281895
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 350 FIFTH AVENUE
STREET 2: SUITE 7530
CITY: NEW YORK
STATE: NY
ZIP: 10118
BUSINESS PHONE: 646-440-9100
MAIL ADDRESS:
STREET 1: 350 FIFTH AVENUE
STREET 2: SUITE 7530
CITY: NEW YORK
STATE: NY
ZIP: 10118
FORMER COMPANY:
FORMER CONFORMED NAME: INOTEK PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20040226
4
1
form4.xml
X0508
4
2023-12-07
0001281895
ROCKET PHARMACEUTICALS, INC.
RCKT
0001996804
Woods Keith
C/O ROCKET PHARMACEUTICALS, INC.
9 CEDARBROOK DRIVE
CRANBURY
NJ
08512
true
false
Stock Option (Right to Buy)
26.3
2023-12-07
4
A
0
20522
0
A
2033-12-07
Common Stock
20522
20522
D
Stock Option (Right to Buy)
26.3
2023-12-07
4
A
0
11960
0
A
2033-12-07
Common Stock
11960
11960
D
This option represents a right to purchase a total of 20,522 shares of the Issuer's common stock, which will vest in equal monthly installments over a three-year period, such that all of the shares underlying this option will be fully vested on December 7, 2026.
This option represents a right to purchase a total of 11,960 shares of the Issuer's common stock, which will fully vest on December 7, 2024.
/s/ Martin Wilson, as attorney-in-fact for Keith Woods
2023-12-12